Medicare to cover Novo’s obesity drug for some patients
Healthcare Dive
MARCH 22, 2024
Two weeks after the FDA updated Wegovy’s label, Medicare changed its stance to allow people with a history of heart disease to receive treatment, a shift that could further boost access to the fast-selling medicine.
Let's personalize your content